AU2003284967A1 - Novel mouse polypeptides encoded by polynucleotides and methods of their use - Google Patents

Novel mouse polypeptides encoded by polynucleotides and methods of their use

Info

Publication number
AU2003284967A1
AU2003284967A1 AU2003284967A AU2003284967A AU2003284967A1 AU 2003284967 A1 AU2003284967 A1 AU 2003284967A1 AU 2003284967 A AU2003284967 A AU 2003284967A AU 2003284967 A AU2003284967 A AU 2003284967A AU 2003284967 A1 AU2003284967 A1 AU 2003284967A1
Authority
AU
Australia
Prior art keywords
polynucleotides
methods
polypeptides encoded
novel mouse
mouse polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003284967A
Other languages
English (en)
Other versions
AU2003284967A8 (en
Inventor
Keting Chu
Yoshihide Hayashizaki
Kevin Hestir
Mamoru Kamiya
Ernestine Lee
Lewis T. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Five Prime Therapeutics Inc
Original Assignee
Five Prime Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc
Publication of AU2003284967A1 publication Critical patent/AU2003284967A1/en
Publication of AU2003284967A8 publication Critical patent/AU2003284967A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003284967A 2002-11-15 2003-10-24 Novel mouse polypeptides encoded by polynucleotides and methods of their use Abandoned AU2003284967A1 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US42691602P 2002-11-15 2002-11-15
US60/426,916 2002-11-15
US43115802P 2002-12-04 2002-12-04
US60/431,158 2002-12-04
US43160602P 2002-12-05 2002-12-05
US43144502P 2002-12-05 2002-12-05
US60/431,445 2002-12-05
US60/431,606 2002-12-05
US47662103P 2003-06-09 2003-06-09
US47663203P 2003-06-09 2003-06-09
US60/476,632 2003-06-09
US60/476,621 2003-06-09
US48521703P 2003-07-08 2003-07-08
US48535903P 2003-07-08 2003-07-08
US60/485,359 2003-07-08
US60/485,217 2003-07-08
US49333203P 2003-08-08 2003-08-08
US49335603P 2003-08-08 2003-08-08
US60/493,356 2003-08-08
US60/493,332 2003-08-08
PCT/US2003/033948 WO2004046310A2 (fr) 2002-11-15 2003-10-24 Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation

Publications (2)

Publication Number Publication Date
AU2003284967A1 true AU2003284967A1 (en) 2004-06-15
AU2003284967A8 AU2003284967A8 (en) 2004-06-15

Family

ID=32330266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003284967A Abandoned AU2003284967A1 (en) 2002-11-15 2003-10-24 Novel mouse polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country Link
AU (1) AU2003284967A1 (fr)
WO (1) WO2004046310A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3554512A4 (fr) * 2016-12-14 2020-07-15 Agency For Science, Technology And Research Procédé de régulation de la fonction d'une cellule cardiaque, nucléotides et composés associés
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004516821A (ja) * 2000-09-01 2004-06-10 エピゲノミクス アーゲー ゲノムＤＮＡ上の、配列コンテクスト５−ＣｐＧ−３内の特定シトシンのメチル化度の定量方法

Also Published As

Publication number Publication date
WO2004046310A3 (fr) 2005-02-17
WO2004046310A2 (fr) 2004-06-03
AU2003284967A8 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
AU2003294217A1 (en) Human polypeptides encoded by polynucleotides and methods of their use
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
AU2003275056A1 (en) Novel lapacho compounds and methods of use thereof
AU2003295343A1 (en) Uses of human zven proteins and polynucleotides
AU2003219900A1 (en) Antigene locks and therapeutic uses thereof
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2003265787A1 (en) Methods of use for novel human polypeptides encoded by polynucleotides
AU2003298606A1 (en) Human polypeptides encoded by polynucleotides and methods of their use
AU2003284967A1 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
PL375356A1 (en) Claudin polypeptides, polynucleotides, and methods of making and use thereof
AUPS283602A0 (en) Improved conversion and encoding techniques
AU2003228802A1 (en) TGF-Alpha POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
AU2003294236A1 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003023002A9 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et procedes d'utilisation associes
AU2003274934A1 (en) Novel mouse polypeptides encode by polynucleotides and methods of their use
AU2003304034A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003060149A9 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
AU2002360460A1 (en) Methods and materials relating to novel polypeptides and polynucleotides
AU2003231152A1 (en) Novel essential fungal polynucleotides, polypeptides, and methods of use
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003270424A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002254163A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002322404A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003274935A1 (en) Novel human polypeptides encoded by polynucleotides
AU2003286636A1 (en) Novel human polypeptides encoded by polynucleotides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase